Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Invested Capital (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Invested Capital for 16 consecutive years, with -$16.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Invested Capital fell 68.17% to -$16.3 million in Q4 2025 year-over-year; TTM through Nov 2025 was -$16.3 million, a 68.17% decrease, with the full-year FY2025 number at -$16.3 million, down 68.17% from a year prior.
  • Invested Capital was -$16.3 million for Q4 2025 at Cryo Cell International, down from -$11.6 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $4.8 million in Q3 2021 to a low of -$16.3 million in Q4 2025.
  • A 5-year average of -$3.3 million and a median of -$2.0 million in 2021 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: soared 350.8% in 2022, then plummeted 1410.55% in 2023.
  • Cryo Cell International's Invested Capital stood at $4.2 million in 2021, then crashed by 82.11% to $748426.0 in 2022, then tumbled by 1410.55% to -$9.8 million in 2023, then grew by 1.15% to -$9.7 million in 2024, then tumbled by 68.17% to -$16.3 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Invested Capital are -$16.3 million (Q4 2025), -$11.6 million (Q3 2025), and -$8.9 million (Q2 2025).